Worldwide Webinar Series:

Impact of Modeling & Simulation in Drug Development

Rosa’s Worldwide Webinar Series fosters the adoption of modeling and simulation by informing a broad audience about the strategic impact it can have on all aspects of research and development.

Since its inception in 2011, this complimentary monthly series has featured select speakers from academia, industry, Rosa client companies, and Rosa itself. The series has drawn many thousands of attendees worldwide from all drug development disciplines.

PLEASE NOTE - ***ALL WEBINARS PRIOR to 2017*** are available by contacting us CLICK HERE 

Sign up to receive Webinar and QSP News Alerts

Date Presenter / Topic Register

Maria Trujillo, PhD
Maria Trujillo is a seasoned quantitative pharmacologist with over 20 years of experience in drug discovery and development, leading enterprise-wide collaborations to address critical strategic and scientific questions through model-informed drug discovery and development (MID3). Dr. Trujillo is an expert in integrating diverse data sources via modeling to accelerate decision-making and advance cardiometabolic therapeutics. She is currently leading efforts and managing a group in the department of Quantitative Pharmacology and Pharmacometrics working in support of the MASH/ Obesity pipeline at Merck.

Accelerating the Discovery and Development of GLP-1 Based Therapeutics with MID3